ロード中...
Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma
The treatment of cancer, especially of various types of solid tumors, has been revolutionized by the blockade of the PD-1/PD-L1 pathway by immune checkpoint inhibitors. Their success amongst hematologic malignancies, however, has been limited so far to the treatment of classic Hodgkin's lymphom...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6250817/ https://ncbi.nlm.nih.gov/pubmed/30505301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02431 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|